|
Proteome-wide analysis of the serological response to vaccinia and smallpox
|
journal
|
May 2007 |
|
Shape Complementarity at Protein/Protein Interfaces
|
journal
|
December 1993 |
|
A Myristylated Membrane Protein Encoded by the Vaccinia Virus L1R Open Reading Frame Is the Target of Potent Neutralizing Monoclonal Antibodies
|
journal
|
August 1995 |
|
Neutralizing and Protective Antibodies Directed against Vaccinia Virus Envelope Antigens
|
journal
|
February 1999 |
|
The Vaccinia Virus A36R Protein Is a Type Ib Membrane Protein Present on Intracellular but Not Extracellular Enveloped Virus Particles
|
journal
|
May 2000 |
|
Generation and Characterization of Monoclonal Antibodies Specific for Vaccinia Virus
|
book
|
January 2012 |
|
A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope
|
journal
|
June 1992 |
|
Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB/c mice from a lethal intranasal poxvirus challenge
|
journal
|
September 2004 |
|
Immune responses to the smallpox vaccine given in combination with ST-246, a small-molecule inhibitor of poxvirus dissemination
|
journal
|
February 2008 |
|
A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE®
|
journal
|
February 2010 |
|
A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge
|
journal
|
September 2010 |
|
Immunogenicity and protection efficacy of subunit-based smallpox vaccines using variola major antigens
|
journal
|
February 2008 |
|
There is an A33-dependent mechanism for the incorporation of B5-GFP into vaccinia virus extracellular enveloped virions
|
journal
|
June 2010 |
|
The inability of vaccinia virus A33R protein to form intermolecular disulfide-bonded homodimers does not affect the production of infectious extracellular virus
|
journal
|
December 2010 |
|
Generation and characterization of a large panel of murine monoclonal antibodies against vaccinia virus
|
journal
|
January 2011 |
|
Quantification of antibody responses against multiple antigens of the two infectious forms of Vaccinia virus provides a benchmark for smallpox vaccination
|
journal
|
November 2006 |
|
Principles of protein-protein interactions.
|
journal
|
January 1996 |
|
A Reality in Our Time--Certification of the Global Eradication of Smallpox
|
journal
|
October 1980 |
|
Multivalent Smallpox DNA Vaccine Delivered by Intradermal Electroporation Drives Protective Immunity in Nonhuman Primates Against Lethal Monkeypox Challenge
|
journal
|
January 2011 |
|
The vaccinia virus F12L protein is associated with intracellular enveloped virus particles and is required for their egress to the cell surface
|
journal
|
January 2002 |
|
Phaser crystallographic software
|
journal
|
July 2007 |
|
A statistic for local intensity differences: robustness to anisotropy and pseudo-centering and utility for detecting twinning
|
journal
|
June 2003 |
|
MolProbity : all-atom structure validation for macromolecular crystallography
|
journal
|
December 2009 |
|
Features and development of Coot
|
journal
|
March 2010 |
|
iMOSFLM : a new graphical interface for diffraction-image processing with MOSFLM
|
journal
|
March 2011 |
|
The CCP4 suite programs for protein crystallography
|
journal
|
September 1994 |
|
Structural and Biochemical Characterization of the Vaccinia Virus Envelope Protein D8 and Its Recognition by the Antibody LA5
|
journal
|
May 2012 |
|
Characterization of Chimpanzee/Human Monoclonal Antibodies to Vaccinia Virus A33 Glycoprotein and Its Variola Virus Homolog In Vitro and in a Vaccinia Virus Mouse Protection Model
|
journal
|
September 2007 |
|
Potent Neutralization of Vaccinia Virus by Divergent Murine Antibodies Targeting a Common Site of Vulnerability in L1 Protein
|
journal
|
July 2014 |
|
Vaccination of BALB/c Mice with Escherichia coli -Expressed Vaccinia Virus Proteins A27L, B5R, and D8L Protects Mice from Lethal Vaccinia Virus Challenge
|
journal
|
April 2008 |
|
Unusual Features of Vaccinia Virus Extracellular Virion Form Neutralization Resistance Revealed in Human Antibody Responses to the Smallpox Vaccine
|
journal
|
February 2013 |
|
Redundancy and Plasticity of Neutralizing Antibody Responses Are Cornerstone Attributes of the Human Immune Response to the Smallpox Vaccine
|
journal
|
January 2008 |
|
The Structure of the Poxvirus A33 Protein Reveals a Dimer of Unique C-Type Lectin-Like Domains
|
journal
|
March 2010 |
|
Isolation and characterization of neutralizing monoclonal antibodies to vaccinia virus
|
journal
|
November 1985 |
|
Vaccinia virus gene D8 encodes a virion transmembrane protein
|
journal
|
October 1988 |
|
The Envelope Protein Encoded by the A33R Gene Is Required for Formation of Actin-Containing Microvilli and Efficient Cell-to-Cell Spread of Vaccinia Virus
|
journal
|
May 1998 |
|
Vaccinia Virus Envelope H3L Protein Binds to Cell Surface Heparan Sulfate and Is Important for Intracellular Mature Virion Morphogenesis and Virus Infection In Vitro and In Vivo
|
journal
|
April 2000 |
|
Protective Immunity to Vaccinia Virus Induced by Vaccination with Multiple Recombinant Outer Membrane Proteins of Intracellular and Extracellular Virions
|
journal
|
October 2004 |
|
Modified Vaccinia Virus Ankara Protects Macaques against Respiratory Challenge with Monkeypox Virus
|
journal
|
June 2005 |
|
Vaccinia Virus H3L Envelope Protein Is a Major Target of Neutralizing Antibodies in Humans and Elicits Protection against Lethal Challenge in Mice
|
journal
|
August 2005 |
|
Combinations of Polyclonal or Monoclonal Antibodies to Proteins of the Outer Membranes of the Two Infectious Forms of Vaccinia Virus Protect Mice against a Lethal Respiratory Challenge
|
journal
|
November 2005 |
|
Antibody-Antigen Complexes
|
journal
|
June 1990 |
|
Necrotic Ulcerated Lesion in a Young Boy Caused by Cowpox Virus Infection
|
journal
|
January 2011 |
|
Active vaccination with vaccinia virus A33 protects mice against lethal vaccinia and ectromelia viruses but not against cowpoxvirus; elucidation of the specific adaptive immune response
|
journal
|
July 2013 |
|
Antibody against Extracellular Vaccinia Virus (EV) Protects Mice through Complement and Fc Receptors
|
journal
|
June 2011 |
|
Emergence of Cowpox: Study of the Virulence of Clinical Strains and Evaluation of Antivirals
|
journal
|
February 2013 |
|
An Increasing Danger of Zoonotic Orthopoxvirus Infections
|
journal
|
December 2013 |
|
Complement-bound human antibodies to vaccinia virus B5 antigen protect mice from virus challenge
|
journal
|
March 2010 |
|
Deaths Attributable to Smallpox Vaccination, 1959 to 1966, and 1968
|
journal
|
April 1970 |
|
Role for the Vaccinia Virus A36R Outer Envelope Protein in the Formation of Virus-Tipped Actin-Containing Microvilli and Cell-to-Cell Virus Spread
|
journal
|
April 1998 |
|
Characterization of vaccinia virus glycoproteins by monoclonal antibody precipitation
|
journal
|
March 1992 |
|
A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope
|
journal
|
June 1992 |
|
Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates
|
journal
|
February 2003 |
|
Safety and immunogenicity of new cell-cultured smallpox vaccine compared with calf-lymph derived vaccine: a blind, single-centre, randomised controlled trial
|
journal
|
January 2005 |
|
Cloning and expression of murine Ig genes from single B cells
|
journal
|
October 2009 |
|
Structural basis for the binding of the neutralizing antibody, 7D11, to the poxvirus L1 protein
|
journal
|
November 2007 |
|
Clonal vaccinia virus grown in cell culture as a new smallpox vaccine
|
journal
|
August 2003 |
|
Duration of antiviral immunity after smallpox vaccination
|
journal
|
August 2003 |
|
IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis
|
journal
|
May 2008 |
|
Phaser crystallographic software
|
journal
|
July 2007 |
|
A statistic for local intensity differences: robustness to anisotropy and pseudo-centering and utility for detecting twinning
|
journal
|
June 2003 |
|
MolProbity : all-atom structure validation for macromolecular crystallography
|
journal
|
December 2009 |
|
Features and development of Coot
|
journal
|
March 2010 |
|
An introduction to data reduction: space-group determination, scaling and intensity statistics
|
journal
|
March 2011 |
|
iMOSFLM : a new graphical interface for diffraction-image processing with MOSFLM
|
journal
|
March 2011 |
|
Structural and Biochemical Characterization of the Vaccinia Virus Envelope Protein D8 and Its Recognition by the Antibody LA5
|
journal
|
May 2012 |
|
Characterization of Chimpanzee/Human Monoclonal Antibodies to Vaccinia Virus A33 Glycoprotein and Its Variola Virus Homolog In Vitro and in a Vaccinia Virus Mouse Protection Model
|
journal
|
September 2007 |
|
Vaccinia Virus F9 Virion Membrane Protein Is Required for Entry but Not Virus Assembly, in Contrast to the Related L1 Protein
|
journal
|
October 2006 |
|
Potent Neutralization of Vaccinia Virus by Divergent Murine Antibodies Targeting a Common Site of Vulnerability in L1 Protein
|
journal
|
July 2014 |
|
Heavily Isotype-Dependent Protective Activities of Human Antibodies against Vaccinia Virus Extracellular Virion Antigen B5
|
journal
|
September 2009 |
|
Vaccinia Virus Extracellular Enveloped Virion Neutralization In Vitro and Protection In Vivo Depend on Complement
|
journal
|
February 2009 |
|
Vaccination of BALB/c Mice with Escherichia coli -Expressed Vaccinia Virus Proteins A27L, B5R, and D8L Protects Mice from Lethal Vaccinia Virus Challenge
|
journal
|
April 2008 |
|
Unusual Features of Vaccinia Virus Extracellular Virion Form Neutralization Resistance Revealed in Human Antibody Responses to the Smallpox Vaccine
|
journal
|
February 2013 |
|
Redundancy and Plasticity of Neutralizing Antibody Responses Are Cornerstone Attributes of the Human Immune Response to the Smallpox Vaccine
|
journal
|
January 2008 |
|
Isolation and characterization of neutralizing monoclonal antibodies to vaccinia virus
|
journal
|
November 1985 |
|
Vaccinia virus gene D8 encodes a virion transmembrane protein
|
journal
|
October 1988 |
|
Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope
|
journal
|
December 1992 |
|
Identification and characterization of an extracellular envelope glycoprotein affecting vaccinia virus egress
|
journal
|
March 1992 |
|
Extracellular vaccinia virus envelope glycoprotein encoded by the A33R gene
|
journal
|
June 1996 |
|
The Envelope Protein Encoded by the A33R Gene Is Required for Formation of Actin-Containing Microvilli and Efficient Cell-to-Cell Spread of Vaccinia Virus
|
journal
|
May 1998 |
|
Vaccinia Virus Envelope H3L Protein Binds to Cell Surface Heparan Sulfate and Is Important for Intracellular Mature Virion Morphogenesis and Virus Infection In Vitro and In Vivo
|
journal
|
April 2000 |
|
The Vaccinia Virus A33R Protein Provides a Chaperone Function for Viral Membrane Localization and Tyrosine Phosphorylation of the A36R Protein
|
journal
|
January 2001 |
|
Protective Immunity to Vaccinia Virus Induced by Vaccination with Multiple Recombinant Outer Membrane Proteins of Intracellular and Extracellular Virions
|
journal
|
October 2004 |
|
Modified Vaccinia Virus Ankara Protects Macaques against Respiratory Challenge with Monkeypox Virus
|
journal
|
June 2005 |
|
Vaccinia Virus H3L Envelope Protein Is a Major Target of Neutralizing Antibodies in Humans and Elicits Protection against Lethal Challenge in Mice
|
journal
|
August 2005 |
|
Combinations of Polyclonal or Monoclonal Antibodies to Proteins of the Outer Membranes of the Two Infectious Forms of Vaccinia Virus Protect Mice against a Lethal Respiratory Challenge
|
journal
|
November 2005 |
|
Active vaccination with vaccinia virus A33 protects mice against lethal vaccinia and ectromelia viruses but not against cowpoxvirus; elucidation of the specific adaptive immune response
|
journal
|
July 2013 |
|
The strategic use of novel smallpox vaccines in the post-eradication world
|
journal
|
July 2011 |
|
Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge.
|
journal
|
November 2005 |
|
Combination therapy of vaccinia virus infection with human anti-H3 and anti-B5 monoclonal antibodies in a small animal model
|
journal
|
January 2010 |
|
Protective Murine and Human Monoclonal Antibodies against Eczema Vaccinatum
|
journal
|
January 2011 |
|
Cutting Edge: Long-Term B Cell Memory in Humans after Smallpox Vaccination
|
journal
|
November 2003 |